Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

Scientific literature on COVID-19 Test Methods and Devices - detail

Comparison of sixteen serological SARS-CoV-2 immunoassays in sixteen clinical laboratories

Detection Principle
IgM, IgG, total antibody
Testing Method Category
Testing Method
Wantai/ELISA total-Ab, CUH/NOVO in-house ELISA total-Ab, Ortho/Vitros total-Ab, YHLO/iFlash-IgG, Ortho/Vitros-IgG, Siemens/Atellica total-Ab, Roche-Elecsys total-Ab, Abbott-Architect-IgG, Abbott/Alinity-IgG, Diasorin/LiaisonXL-IgG, Siemens/Vista total-Ab, Euroimmun/ELISA-IgG, Snibe/Maglumi-IgG
Testing Method - Additional Info
comparison of 15 commercial and 1 in-house anti-SARS-CoV-2 assays in 16 laboratories
Reported Performance
specificity: ? 99% (All except one), 97.2% (Diasorin/LiaisonXL-IgG ); sensitivity: 96.7% (Wantai/ELISA total-Ab), 96.0% (CUH/NOVO in-house ELISA total-Ab), 95.3% (Ortho/Vitros total-Ab), 94.0% (YHLO/iFlash-IgG), 93.3% (Ortho/Vitros-IgG), 93.2% (Siemens/Atellica total-Ab), 92.7% (Roche-Elecsys total-Ab), 90.0% (Abbott-Architect-IgG), 88.0% (Abbott/Alinity-IgG), 84.6% (Diasorin/LiaisonXL-IgG), 81.0% (Siemens/Vista total-Ab), 78.0% (Euroimmun/ELISA-IgG), 78.0% (Snibe/Maglumi-IgG).
Sample Size
150 samples
Assay Type

The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements